1
Wealth Management & Retirement
Tag: biotech
VC Funding Cools Slightly as Investors Back Infrastructure, Biotech, and AI Giants in Weekly Top 10
Startup investors may not be hitting the pause button entirely on venture capital deployments, but recent market activity indicates a noticeable scaling back on mega-rounds. For the week spanning October 10 through October 16, 2026, venture capital activity saw only two startup financings cross the multiple-hundred-million-dollar threshold. Despite the quieter pace at the very top…
U.S. Startup Funding Cools Slightly as Investors Back Select Megadeals in AI, Biotech, and Infrastructure
Startup investors may not be hitting the pause button entirely on venture capital deployment, but they certainly scaled back on mega-rounds over the past week. While the market continues to see robust interest in transformative technologies, only two startup financings crossed the multiple-hundred-million-dollar threshold during the tracking period. The largest transaction of the week went…
US Venture Investors Scale Back Mega-Rounds as AI, Biotech, and Infrastructure Lead the Week
Startup investors may not be hitting the pause button entirely on venture capital deployments, but a noticeable shift toward caution rippled through the market this past week. Following weeks of astronomical funding spikes dominated by multiple nine-figure and ten-figure syndicates, venture capitalists scaled back on giant rounds. During this mid-October 2026 cycle, only two startup…
U.S. Startup Investors Scale Back Mega-Rounds as AI, Biotech, and Infrastructure Lead Weekly Funding
Startup investors may not be hitting the pause button entirely on venture capital deployments, but the ecosystem saw a noticeable contraction in the size of mega-rounds this past week. With just two startup financings crossing the multiple-hundred-million-dollar threshold, the latest weekly tally reflects a more measured approach from institutional backers navigating the macroeconomic climate. While…
VC Funding Cools Slightly as Investors Back Infrastructure, Biotech, and AI Giants in 2026
Venture capital investors may not be hitting the pause button entirely on startup investments, but the landscape saw a noticeable cooling off in giant, multi-hundred-million-dollar rounds this past week. While capital continues to flow heavily into high-conviction sectors like artificial intelligence, biotechnology, and specialized infrastructure, only two startups managed to secure financing rounds in the…
